{
  "main_header": {
    "sid": 997896,
    "name": "Bombay Oxygen",
    "stock_name": "Bombay Oxygen",
    "full_name": "Bombay Oxygen Investments Ltd",
    "name_url": "stocks-analysis/bombay-oxygen",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "24,002.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "24,002.00",
    "mcapval": "375.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 509470,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 22,
    "indexname": "",
    "isin": "INE01TL01014",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "19 ",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bombay-oxygen-997896-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Bombay Oxygen falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bombay-oxygen-fallingrising-3752478",
        "imagepath": "",
        "date": "2025-12-09 01:13:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Bombay Oxygen’s share price has been on a downward trajectory over the past week, registering a decline of 4.69%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. The one-month performance further emphasises this trend, with the stock dropping 5.70% while the Sensex gained 2.27%. Year-to-date figures reveal a stark contrast, as Bombay Oxygen has lost 23.90% in value compared to the Sensex’s 8.91% gain. Over the last year, the stock’s decline deepens to 29.50%, whereas the benchmark index rose by 4.15%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p><strong>Intraday and Short-Term Technical Indicators</strong></p>\n<p>On 08-Dec, the stock touched an i..."
      },
      {
        "title": "Why is Bombay Oxygen falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bombay-oxygen-fallingrising-3691344",
        "imagepath": "",
        "date": "2025-11-11 23:29:08",
        "description": "As of 11-Nov, Bombay Oxygen Investments Ltd is experiencing a decline in its stock price, currently at Rs 23,277.00, which reflects a decrease of Rs 423.0 or 1.78%. The stock has been underperforming, having lost 3.29% over the last three days, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown significant underperformance over various periods, with a year-to-date decline of 21.23% compared to a 7.34% increase in the Sensex. Although there has been a rise in delivery volume by 36.36% against the 5-day average, the overall negative momentum and consecutive price falls indicate a challenging environment for the stock.\n\nBroader Market Context: In the short term, Bombay Oxygen's performance has been notably weaker than the benchmark, with a 1-week return of -1.98% compared to the Sensex's gain of 0.49%. This trend of underperformance is con..."
      },
      {
        "title": "Is Bombay Oxygen overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bombay-oxygen-overvalued-or-undervalued-3668734",
        "imagepath": "",
        "date": "2025-11-04 08:08:50",
        "description": "As of 3 November 2025, the valuation grade for Bombay Oxygen has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios indicate significant financial distress, with a PE ratio of -42.06, an EV to EBITDA of -32.75, and a Price to Book Value of just 0.07, highlighting the company's struggles in generating profits and managing its capital effectively.\n\nIn comparison to its peers, Bombay Oxygen's valuation metrics are starkly unfavorable. For instance, Linde India, categorized as very expensive, has a PE ratio of 114.15, while Petronet LNG, rated very attractive, boasts a PE of 11.54. The stark contrast in these ratios underscores the challenges faced by Bombay Oxygen in the current market landscape. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -16.78%, significantly lagging behind the Sensex's gain of 7.47% ..."
      },
      {
        "title": "How has been the historical performance of Bombay Oxygen?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bombay-oxygen-3668208",
        "imagepath": "",
        "date": "2025-11-03 22:55:00",
        "description": "Answer:\nThe historical performance of Bombay Oxygen shows a steady increase in net sales and profit over the years from 2009 to 2011.\n\nBreakdown:\nBombay Oxygen's net sales rose from 32.51 Cr in March 2009 to 41.74 Cr in March 2011, indicating a consistent growth trend. The total operating income mirrored this increase, reaching 41.74 Cr in March 2011, up from 32.51 Cr in March 2009. The company's operating profit (PBDIT) also improved significantly, growing from 4.59 Cr in March 2009 to 8.84 Cr in March 2011. Profit before tax followed a similar upward trajectory, increasing from 0.90 Cr in March 2009 to 5.24 Cr in March 2011, while profit after tax rose from 0.59 Cr to 4.15 Cr in the same period. The earnings per share (EPS) saw a remarkable rise from 39.13 in March 2009 to 276.4 in March 2011. However, cash flow from operating activities showed a decline, moving from 3.74 Cr in March 2009 to -0.42 Cr in M..."
      },
      {
        "title": "Bombay Oxygen Investments Faces Significant Financial Challenges Amid Declining Sales and Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bombay-oxygen-investments-financial-trend-shifts-from-flat-to-negative-amid-declining-performance-3665199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BombayOxygenInv_fintrenddot_3665199.png",
        "date": "2025-11-03 08:00:17",
        "description": "Bombay Oxygen Investments, a microcap NBFC, reported net sales of Rs 23.19 crore for the quarter ending September 2025, a notable decline. Despite a profit after tax of Rs 19.01 crore over six months, the company faced substantial losses in profit metrics and underperformed against the Sensex over the past year."
      },
      {
        "title": "How has been the historical performance of Bombay Oxygen?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bombay-oxygen-3662807",
        "imagepath": "",
        "date": "2025-10-31 22:41:58",
        "description": "Answer:\nThe historical performance of Bombay Oxygen shows a steady increase in net sales and profit over the years, particularly from 2009 to 2011.\n\nBreakdown:\nBombay Oxygen's net sales rose from 32.51 Cr in March 2009 to 41.74 Cr in March 2011, reflecting a consistent growth trend. The total operating income followed the same trajectory, increasing from 32.51 Cr in March 2009 to 41.74 Cr in March 2011. Operating profit, excluding other income, improved significantly from 1.99 Cr in March 2009 to 6.59 Cr in March 2011, indicating enhanced operational efficiency. The profit before tax also saw a substantial rise, moving from 0.90 Cr in March 2009 to 5.24 Cr in March 2011. Consequently, profit after tax increased from 0.59 Cr in March 2009 to 4.15 Cr in March 2011, showcasing a strong improvement in profitability. The earnings per share (EPS) surged from 39.13 in March 2009 to 276.4 in March 2011, reflecting ..."
      },
      {
        "title": "Are Bombay Oxygen latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bombay-oxygen-latest-results-good-or-bad-3662390",
        "imagepath": "",
        "date": "2025-10-31 19:18:45",
        "description": "The latest financial results for Bombay Oxygen reveal a company facing significant operational challenges. In Q2 FY26, the company reported a net loss of ₹5.22 crore, indicating a loss-making quarter, which raises concerns about its financial health. The net sales for the quarter were ₹9.79 crore, reflecting a modest sequential growth of 8.06% from the previous quarter, but this still represents a year-on-year decline of 0.81%. \n\nFor the first half of FY26, the revenue was ₹23.19 crore, which shows a dramatic contraction of 56.23% compared to the same period last year. This substantial drop in revenue raises fundamental questions about the sustainability of the company's business model. The profitability metrics are also concerning, with a net profit of ₹0.52 crore in Q2 FY26, down 71.74% year-on-year, and a significant compression in profit margins.\n\nThe return on equity (ROE) has fallen to 3.08%, well bel..."
      },
      {
        "title": "Bombay Oxygen Investments Q2 FY26: Severe Profitability Crisis Deepens Amid Operational Struggles",
        "link": "https://www.marketsmojo.com/news/result-analysis/bombay-oxygen-investments-q2-fy26-severe-profitability-crisis-deepens-amid-operational-struggles-3662323",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BombayOxygenInv_quaterlyResult_3662323.png",
        "date": "2025-10-31 17:47:00",
        "description": "Bombay Oxygen Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹372.00 crores, has reported deeply concerning financial results for Q2 FY26 ended September 2025. The company posted a consolidated net loss of ₹5.22 crores, representing a dramatic reversal from profitability and marking a sequential decline of over 240% compared to the previous four-quarter average. The stock, currently trading at ₹24,605.00, has declined 0.75% following the results announcement, reflecting investor anxiety over the deteriorating operational performance and negative financial momentum."
      },
      {
        "title": "Bombay Oxygen Investments Faces Declining Performance Amid Market Adjustments in NBFC Sector",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bombay-oxygen-investments-stock-downgraded-from-hold-to-sell-by-marketsmojo-3618763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BombayOxygenInv_mojoScore_3618763.png",
        "date": "2025-10-14 09:02:38",
        "description": "Bombay Oxygen Investments, a microcap in the NBFC sector, has recently experienced a change in its evaluation, reflecting a shift in market sentiment. The company has faced significant performance challenges, with notable declines in net sales and profits over recent periods, while trading at a premium compared to peers."
      }
    ],
    "total": 103,
    "sid": "997896",
    "stock_news_url": "https://www.marketsmojo.com/news/bombay-oxygen-investments-997896"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Nov-2025",
      "details": "Intimation of Newspaper Publication on 1st November 2025 w.r.t. Unaudited Financial Results for the quarter and half year ended 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September 2025",
      "datetime": "31-Oct-2025",
      "details": "Please find attached herewith Unaudited Financial Results for the Quarter and Half Year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "31-Oct-2025",
      "details": "Appointment of Ms. Anshika Pal (A78049) as the Company Secretary and Compliance Officer of the Company with effect from 1st November 2025 as detailed in the enclosed attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bombay Oxygen Investments Ltd has declared <strong>35%</strong> dividend, ex-date: 08 Jul 25",
          "dt": "2025-07-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Bombay Oxygen falling/rising?

2025-12-09 01:13:11

Recent Price Movement and Market Context

Bombay Oxygen’s share price has been on a downward trajectory over the past week, registering a decline of 4.69%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. The one-month performance further emphasises this trend, with the stock dropping 5.70% while the Sensex gained 2.27%. Year-to-date figures reveal a stark contrast, as Bombay Oxygen has lost 23.90% in value compared to the Sensex’s 8.91% gain. Over the last year, the stock’s decline deepens to 29.50%, whereas the benchmark index rose by 4.15%. These figures highlight a persistent underperformance relative to the broader market.

Intraday and Short-Term Technical Indicators

On 08-Dec, the stock touched an i...

Read More

Why is Bombay Oxygen falling/rising?

2025-11-11 23:29:08

As of 11-Nov, Bombay Oxygen Investments Ltd is experiencing a decline in its stock price, currently at Rs 23,277.00, which reflects a decrease of Rs 423.0 or 1.78%. The stock has been underperforming, having lost 3.29% over the last three days, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown significant underperformance over various periods, with a year-to-date decline of 21.23% compared to a 7.34% increase in the Sensex. Although there has been a rise in delivery volume by 36.36% against the 5-day average, the overall negative momentum and consecutive price falls indicate a challenging environment for the stock. Broader Market Context: In the short term, Bombay Oxygen's performance has been notably weaker than the benchmark, with a 1-week return of -1.98% compared to the Sensex's gain of 0.49%. This trend of underperformance is con...

Read More

Is Bombay Oxygen overvalued or undervalued?

2025-11-04 08:08:50

As of 3 November 2025, the valuation grade for Bombay Oxygen has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios indicate significant financial distress, with a PE ratio of -42.06, an EV to EBITDA of -32.75, and a Price to Book Value of just 0.07, highlighting the company's struggles in generating profits and managing its capital effectively. In comparison to its peers, Bombay Oxygen's valuation metrics are starkly unfavorable. For instance, Linde India, categorized as very expensive, has a PE ratio of 114.15, while Petronet LNG, rated very attractive, boasts a PE of 11.54. The stark contrast in these ratios underscores the challenges faced by Bombay Oxygen in the current market landscape. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -16.78%, significantly lagging behind the Sensex's gain of 7.47% ...

Read More

How has been the historical performance of Bombay Oxygen?

2025-11-03 22:55:00

Answer: The historical performance of Bombay Oxygen shows a steady increase in net sales and profit over the years from 2009 to 2011. Breakdown: Bombay Oxygen's net sales rose from 32.51 Cr in March 2009 to 41.74 Cr in March 2011, indicating a consistent growth trend. The total operating income mirrored this increase, reaching 41.74 Cr in March 2011, up from 32.51 Cr in March 2009. The company's operating profit (PBDIT) also improved significantly, growing from 4.59 Cr in March 2009 to 8.84 Cr in March 2011. Profit before tax followed a similar upward trajectory, increasing from 0.90 Cr in March 2009 to 5.24 Cr in March 2011, while profit after tax rose from 0.59 Cr to 4.15 Cr in the same period. The earnings per share (EPS) saw a remarkable rise from 39.13 in March 2009 to 276.4 in March 2011. However, cash flow from operating activities showed a decline, moving from 3.74 Cr in March 2009 to -0.42 Cr in M...

Read More

Bombay Oxygen Investments Faces Significant Financial Challenges Amid Declining Sales and Returns

2025-11-03 08:00:17

Bombay Oxygen Investments, a microcap NBFC, reported net sales of Rs 23.19 crore for the quarter ending September 2025, a notable decline. Despite a profit after tax of Rs 19.01 crore over six months, the company faced substantial losses in profit metrics and underperformed against the Sensex over the past year.

Read More

How has been the historical performance of Bombay Oxygen?

2025-10-31 22:41:58

Answer: The historical performance of Bombay Oxygen shows a steady increase in net sales and profit over the years, particularly from 2009 to 2011. Breakdown: Bombay Oxygen's net sales rose from 32.51 Cr in March 2009 to 41.74 Cr in March 2011, reflecting a consistent growth trend. The total operating income followed the same trajectory, increasing from 32.51 Cr in March 2009 to 41.74 Cr in March 2011. Operating profit, excluding other income, improved significantly from 1.99 Cr in March 2009 to 6.59 Cr in March 2011, indicating enhanced operational efficiency. The profit before tax also saw a substantial rise, moving from 0.90 Cr in March 2009 to 5.24 Cr in March 2011. Consequently, profit after tax increased from 0.59 Cr in March 2009 to 4.15 Cr in March 2011, showcasing a strong improvement in profitability. The earnings per share (EPS) surged from 39.13 in March 2009 to 276.4 in March 2011, reflecting ...

Read More

Are Bombay Oxygen latest results good or bad?

2025-10-31 19:18:45

The latest financial results for Bombay Oxygen reveal a company facing significant operational challenges. In Q2 FY26, the company reported a net loss of ₹5.22 crore, indicating a loss-making quarter, which raises concerns about its financial health. The net sales for the quarter were ₹9.79 crore, reflecting a modest sequential growth of 8.06% from the previous quarter, but this still represents a year-on-year decline of 0.81%. For the first half of FY26, the revenue was ₹23.19 crore, which shows a dramatic contraction of 56.23% compared to the same period last year. This substantial drop in revenue raises fundamental questions about the sustainability of the company's business model. The profitability metrics are also concerning, with a net profit of ₹0.52 crore in Q2 FY26, down 71.74% year-on-year, and a significant compression in profit margins. The return on equity (ROE) has fallen to 3.08%, well bel...

Read More

Bombay Oxygen Investments Q2 FY26: Severe Profitability Crisis Deepens Amid Operational Struggles

2025-10-31 17:47:00

Bombay Oxygen Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹372.00 crores, has reported deeply concerning financial results for Q2 FY26 ended September 2025. The company posted a consolidated net loss of ₹5.22 crores, representing a dramatic reversal from profitability and marking a sequential decline of over 240% compared to the previous four-quarter average. The stock, currently trading at ₹24,605.00, has declined 0.75% following the results announcement, reflecting investor anxiety over the deteriorating operational performance and negative financial momentum.

Read More

Bombay Oxygen Investments Faces Declining Performance Amid Market Adjustments in NBFC Sector

2025-10-14 09:02:38

Bombay Oxygen Investments, a microcap in the NBFC sector, has recently experienced a change in its evaluation, reflecting a shift in market sentiment. The company has faced significant performance challenges, with notable declines in net sales and profits over recent periods, while trading at a premium compared to peers.

Read More

View All News